GLP-3 (Retatrutide) as a Research Material: Structure, Identity Testing and Handling

GLP-3 (retatrutide) is the name under which PepXtide lists this material. "GLP-3" is a catalogue name, not a formal nomenclature term; the compound is retatrutide, also known by the research code LY3437943. It is supplied for laboratory research use only; not for human consumption. This article covers what the molecule is, how its identity is checked on a certificate, and how a lipidated peptide of this length is handled at the bench.

Structure

Retatrutide is a 39-residue lipopeptide built on a GIP-derived backbone (PMID: 35985340). Three non-proteinogenic features stand out. Alpha-aminoisobutyric acid (Aib) sits at positions 2 and 20, and alpha-methyl-leucine at position 13. These quaternary alpha-carbon residues restrict backbone conformation and are also difficult to couple during synthesis. The C-terminus is a serine amide.

The lipid is attached at Lys17. A C20 eicosanedioic diacid is linked to the lysine side chain through a gamma-glutamate and a single oligoethylene-glycol spacer. This substituent accounts for much of the molecule's hydrophobic character.

The complete molecule has a mass of 4,731.33 g/mol. Some registries list a figure near 4,092 Da, which corresponds to the backbone alone, without the linker and diacid. The difference is roughly 640 Da. Anyone comparing a certificate against a database entry should check which of the two masses the entry describes.

In-vitro receptor pharmacology

As a bench measurement, retatrutide was characterised in cell-based cAMP assays at the human GIP, GLP-1 and glucagon receptors (PMID: 35985340). The half-maximal concentrations fall in the sub-nanomolar to low-nanomolar range. Potency is highest at the GIP receptor, lower at the GLP-1 receptor and lowest at the glucagon receptor. Exact values depend on the cell line, receptor expression level and assay format, so the original paper should be consulted before any figure is used as a reference point for a new assay.

Synthesis of a long lipidated peptide

Making a 39-residue peptide with hindered residues and a lipid side chain is demanding. Solid-phase synthesis is the usual route. Aib and alpha-methyl-leucine couplings are slow and can leave deletion sequences. Lys17 needs an orthogonally protected side chain so that the spacer, gamma-glutamate and diacid can be added selectively. After cleavage, crude material contains closely related species: truncations, deletions and incompletely acylated products. Preparative reversed-phase chromatography is then used to separate them.

Alternative approaches are published. One describes a hydrophobic tag-assisted liquid-phase strategy for retatrutide (PMID: 42224238). It is relevant here because the way a batch is made influences which minor species can be present, and this is one reason the analytical record for a batch matters.

How identity is confirmed on a certificate

Two measurements carry most of the weight: liquid chromatography with high-resolution mass spectrometry (LC-HRMS) and HPLC compared against a reference standard. LC-HRMS methods for detecting the intact retatrutide molecule have been described in the literature (PMID: 42745421). For a peptide this size, the spectrum shows a series of multiply charged ions. These are deconvoluted to a neutral mass, which is compared with the theoretical value for the complete lipidated molecule. A result near 4,092 Da would point to a molecule lacking its lipid substituent. A result matching 4,731.33 g/mol is consistent with the intact structure. Analysts should also note whether a reported figure is monoisotopic or average, since the two differ by several daltons at this size.

The lipid tail also affects chromatography. The C20 diacid makes the molecule markedly more retained on reversed-phase columns than an unlipidated backbone, so retention time compared against a reference standard is informative about whether the acyl group is present. A co-eluting or shifted peak is a reason to look closer.

A certificate reports what one laboratory measured on one batch. The testing laboratory is third-party and named on the report, and the document is identified by its Report ID or Laboratory ID. Certificates for some strengths are still pending, so check the product page for a published report and its Report ID before relying on any figure.

Handling and storage

Lipopeptides behave differently from plain peptides in the lab. The hydrophobic tail promotes adsorption to plastic and glass surfaces, so low-binding tubes and minimal transfer steps reduce losses. Solubility can be limited in purely aqueous media, and self-association or aggregation may occur at higher concentrations. When a stock solution is prepared as a bench reagent for an assay, the solvent choice and any pH adjustment should be recorded, and the solution inspected for turbidity before it is diluted into assay buffer.

Lyophilised material is generally kept cold, dry and protected from light. The sealed vial should reach room temperature before opening so that condensation does not add water to the solid. Stock solutions are best divided into small aliquots to avoid repeated freeze-thaw cycles, and each aliquot should be labelled with the certificate's Report ID or Laboratory ID for traceability.

To summarise, retatrutide's identity depends on the whole lipidated structure, and its analytical record depends on measurements that can distinguish that structure from its backbone alone. This material is for laboratory research use only; not for human consumption.